Showing results (1921-1930 of 2,232) with videos related to
Sort By:
Pageof 224
Journal of the American Chemical Society|December 3, 2024
Catalytic Intermolecular Asymmetric [2π + 2σ] Cycloadditions of Bicyclo[1.1.0]butanes: Practical Synthesis of Enantioenriched Highly Substituted Bicyclo[2.1.1]hexanesYing-Jie Li, Zhi-Long Wu, Qiang-Shuai Gu, et al.Journal of Materials Chemistry. B|April 9, 2020
Imaging guided photothermal therapy using iron oxide loaded poly(lactic acid) microcapsules coated with graphene oxideXiao-Da Li, Xiao-Long Liang, Xiu-Li Yue, et al.Clinical Lung Cancer|October 18, 2024
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R MutationQing Zhou, Jie Li, Shun-Dong Cang, et al.Journal for Immunotherapy of Cancer|July 18, 2023
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancerJia-Yi Deng, Qing Gou, Lingling Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating MutationsTony S Mok, Ying Cheng, Xiangdong Zhou, et al.Thoracic Cancer|July 12, 2022
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employeesZi-Hao Chen, Zhi-Yong Chen, Jing Kang, et al.Clinical Lung Cancer|June 20, 2025
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, et al.British Journal of Cancer|December 23, 2016
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6Yi-Long Wu, Lecia V Sequist, Cheng-Ping Hu, et al.Annals of Translational Medicine|March 12, 2021
Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trialLi Zhang, Shun Lu, Ying Cheng, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland ChinaYi-Long Wu, Wen-Zhao Zhong, Long-Yun Li, et al.Pageof 224